北米のエキソソーム研究製品市場、製品別（機器および消耗品）、適応症別（がんおよび非がん）、用途別（治療薬および診断薬）、エンドユーザー別（病院、臨床検査研究所、研究センター、製薬およびバイオテクノロジー企業、学術機関など）、流通チャネル別（サードパーティの販売代理店、オンライン、直接入札など）の業界動向と2030年までの予測。
北米のエクソソーム研究製品市場分析と洞察
がんやさまざまな自己免疫疾患の罹患率と発症率の増加により、市場の需要が高まっています。より良い医療サービスを求める医療費の増加も、市場の成長に貢献しています。主要な市場プレーヤーは、この重要な時期にさまざまなサービスの立ち上げと承認に重点を置いています。さらに、製薬研究開発とライフサイエンス研究への投資の増加も、エキソソーム研究製品のテストに対する需要の増加に貢献しています。
北米のエクソソーム研究製品市場は、市場プレーヤーの増加と高度なサービスの利用可能性により、予測年度に成長すると予想されています。これに伴い、メーカーは市場で新しいサービスを開始するための研究開発活動に取り組んでいます。
しかし、エクソソームの開発と製造に関するゴールドスタンダードプロトコルが欠如しているため、予測期間中の北米のエクソソーム研究製品市場の成長が妨げられる可能性があります。
エクソソーム技術のさらなる進歩により、市場に治療を強化する機会が生まれることが期待されます。
しかし、エクソソーム研究製品に伴う副作用や製品発売に伴う承認の遅れが、市場の成長を妨げる可能性があります。
データブリッジマーケットリサーチは、北米のエクソソーム研究製品市場は、予測期間中に35.5％のCAGRで成長し、2030年までに9,33,848.80千米ドルに達すると予測しています。診断および治療におけるエクソソーム研究製品の使用が増加しているため、製品は市場で最大のタイプセグメントを占めています。
|
レポートメトリック |
詳細 |
|
予測期間 |
2023年から2030年 |
|
基準年 |
2022 |
|
歴史的な年 |
2021 (2015～2020年にカスタマイズ可能) |
|
定量単位 |
売上高は千米ドル、販売数量は個数、価格は米ドル |
|
対象セグメント |
製品別（機器および消耗品）、適応症別（がんおよび非がん）、用途別（治療薬および診断薬）、エンドユーザー別（病院、臨床検査研究所、研究センター、製薬およびバイオテクノロジー企業、学術機関、その他）、流通チャネル別（サードパーティの販売代理店、オンライン、直接入札） |
|
対象国 |
米国、カナダ、メキシコ |
|
対象となる市場プレーヤー |
北米のエクソソーム研究製品市場で活動している主要企業には、Hologic Inc.、Luminex Corporation、Thermo Fisher Scientific、Agilent Technologies、Inc.、RoosterBio、Inc.、Cell Guidance Systems LLC、QIAGEN、FUJIFILM Irvine Scientific（FUJIFILM Holdings Corporationの子会社）、CUSABIO TECHNOLOGY LLC、NEXOSOME-ONCOLOGY、Norgen Biotek Corp.、Miltenyi Biotec、Aethlon Medical、Inc.、System Biosciences、LLC、AMSBIO、ExoDx（Bio-Techneが買収）、BioVision Inc.（Abcam plcが買収）、Creative Bioarray、NanoSomiX、Novus Biologicals、Beckman Coulter、Inc.、Hitachi、Ltd.、ProteoGenex、Audubon Bioscienceなどがあります。 |
北米のエクソソーム研究製品市場の定義
エクソソームは、エンドソームで構成される細胞由来の細胞外小胞の特定のクラスであり、通常、直径は 30 ～ 150 nm で、最も小さいタイプの細胞外小胞です。脂質二重層で保護されたエクソソームは、元の細胞に由来する複雑な貨物を内包して細胞外環境に押し出されます。貨物に含まれる内容物は、タンパク質、脂質、メッセンジャーリボ核酸 (mRNA)、ミクロソームリボ核酸 (miRNA)、およびデオキシリボ核酸 (DNA) です。
エクソソームは、自己免疫疾患などのさまざまな慢性疾患の治療に利用されています。エクソソーム療法は、薬物送達、腫瘍免疫療法、診断バイオマーカーに広く使用されています。エクソソームは、その小さなサイズ、天然の性質、および生物学的障壁を越える能力により、薬物キャリアとして使用されています。
北米のエクソソーム研究製品市場の動向
このセクションでは、市場の推進要因、利点、機会、制約、課題について理解します。これらについては、以下で詳しく説明します。
ドライバー
- 癌、慢性炎症、自己免疫疾患、ライム病、その他の慢性変性疾患の罹患率の増加
WHOによると、がんは世界的に死亡原因のトップであり、2020年には約1,000万人が亡くなりました。インドでは、2020年の男性のがん患者数は約679,421人、女性は約712,758人でした。2021年の米国の新規がん症例数と死亡者数は約190万人、がんによる死亡者は608,570人でした。このように、がんの発生率は研究者にますます多くの研究を促しており、バイオマーカーはがんの診断に役立ちます。したがって、市場の成長が加速しています。
したがって、結論として、心血管疾患、神経障害、その他のさまざまな慢性疾患などの慢性疾患の増加により、さまざまな医薬品の需要が増加し、今後数年間で北米のエキソソーム研究製品市場の成長を促進することになります。
- 医薬品研究開発およびライフサイエンス研究への投資の増加
Academic and research institutes, pharmaceutical and biotechnology businesses, hospitals, and clinical testing laboratories are the major end users of the market. There has been a rise in demand for exosome studies in recent years due to their potential in illness detection and their emerging role as intercellular messengers. This has attracted the interest of several academic researchers, leading to the market's growth. More than 6,000 items are currently being examined in clinical trials worldwide, representing a 68% increase over 2016, per the Pharmaceutical R&D spending trends in 2022.
As the market players are constantly engaged in research and developmental activities, more hybrid and natural exosomes are being introduced in the North America exosome research products market. This would increase the demand for exosome therapeutics to treat cancer and auto-immune diseases in hospitals and diagnostic centers. Hence, the advancements in research and development activities and increasing investments in the pharmaceutical sector are expected to drive overall market growth.
Restraint
- Lack of gold standard protocols for the development and production of exosomes
The field of exosomes is still at a nascent stage, and no gold standards have been developed so far. Thus the professionals employ new procedures and methodologies in the market without hesitation. In addition to researchers making mistakes during exosome production, scientists face various challenges in exosome research and development and manufacturing activities.
The lack of authentication and safety of the exosomes would hinder the safety protocols and the production of natural and hybrid exosomes. Hence, the lack of standard protocols in developing exosomes and the absence of authentication requirements for the isolation of exosomes are expected to restrain the growth of the exosome research products market.
Opportunity
-
Rise in demand for specialized testing services among end users
Exosomes are small (30–150 nm) vesicles containing sophisticated RNA and protein cargo that are constantly secreted by all cells in vitro and in vivo. Exosomes are changing research due to the intriguing functions within the human body, including intercellular communication and signaling.
Henceforth, the rising use of specialized testing services such as liquid chromatography-mass spectrometry, RNA sequencing, wet chemistry, gene expressions, and various other testing services act as a driver for the growth of the exosome research product market and the ability of these testing services to provide accurate results with precision which has increased the demand among end users.
Challenge
- Side effects associated with exosome research products
While all medical treatments have benefits and risks, unapproved exosome products expose patients to potential risks without a clear benefit. These products may potentially treat many medical conditions and diseases, but further research is needed to know whether the products have any benefit or are safe to use. The side effects may include injection site reaction, failure of the cells to work as expected, growth of tumors, infections, and the potential for contamination of the product, the ability of cells to move from placement sites and multiply or change into inappropriate cell types
Henceforth, the various side effects of exosome research products for their diagnosis safety, cost, and convenience issues are expected to challenge the North America exosome research products market.
Recent Developments
- In July 2022, Aethlon Medical, Inc., a medical therapy company focused on developing products for the diagnosis and treatment of cancer and life-threatening infectious diseases, announced that the US Food and Drug Administration (FDA) had approved a protocol amendment for an ongoing clinical trial of Aethlon Hemopurifier for patients with severe COVID-19
- In April 2020, ExoDX launched the ExoDx Prostate Test Home Collection Kit for patients concerned about prostate health. The home collection kit provides an immediate and cost-effective solution that enables a telemedicine/telehealth option for physicians and their patients who share the frustration, anxiety, and fear of the advanced prostate cancer patient
North America Exosome Research Products Market Scope
North America exosome research products market is segmented into five notable segments such as product, indication, application, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT
- INSTRUMENTS
- Consumables
On the basis of product, the North America exosome research products market is segmented into instruments and consumables.
NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION
- CANCER
- NON CANCER
On the basis of indication, the North America exosome research products market is segmented into cancer and non-cancer.
NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION
- THERAPEUTICS
- DIAGNOSTICS
On the basis of application, the North America exosome research products market is segmented into therapeutics and diagnostics.
NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY END USERS
- HOSPITALS
- CLINICAL TESTING LABORATORIES
- RESEARCH CENTERS
- PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY
- ACADEMIC INSTITUTES
- OTHERS
On the basis of end users, the North America exosome research products market is segmented into hospitals, clinical testing laboratory, research centers, pharmaceutical and biotechnology company, academic institutes, and others.
北米のエクソソーム研究製品市場（流通チャネル別）
- サードパーティディストリビューター
- オンライン
- 直接入札
流通チャネルに基づいて、北米のエクソソーム研究製品市場は、サードパーティの販売代理店、オンライン、直接入札に分類されます。
北米のエクソソーム研究製品市場地域分析/洞察
北米のエクソソーム研究製品市場は、製品、適応症、用途、エンドユーザー、流通チャネルなど、5 つの主要なセグメントに分類されます。
この市場レポートでカバーされている国は、米国、カナダ、メキシコです。
米国は、高いGDPを誇る最大の消費者市場に主要な市場プレーヤーが存在することから、北米地域で優位に立つと予想されています。
レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える個々の市場影響要因と国内規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、個々の国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、北米ブランドの存在と可用性、地元および国内ブランドとの競争が激しいか少ないために直面する課題、販売チャネルの影響も考慮されます。
競争環境と北米のエクソソーム研究製品の市場シェア分析
北米のエクソソーム研究製品市場の競争環境は、競合他社の詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、製品の幅と幅、アプリケーションの優位性、技術ライフライン曲線などがあります。上記のデータポイントは、北米のエクソソーム研究製品市場への会社の焦点にのみ関連しています。
北米のエクソソーム研究製品市場で活動している主要企業には、Hologic Inc.、Luminex Corporation、Thermo Fisher Scientific、Agilent Technologies, Inc.、RoosterBio, Inc.、Cell Guidance Systems LLC、QIAGEN、FUJIFILM Irvine Scientific（FUJIFILM Holdings Corporation の子会社）、CUSABIO TECHNOLOGY LLC、NEXOSOME-ONCOLOGY、Norgen Biotek Corp.、Miltenyi Biotec、Aethlon Medical, Inc.、System Biosciences, LLC.、AMSBIO、ExoDx（Bio-Techne が買収）、BioVision Inc.（Abcam plc が買収）、Creative Bioarray、NanoSomiX、Novus Biologicals、Beckman Coulter, Inc.、Hitachi, Ltd.、ProteoGenex、Audubon Bioscience などがあります。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
4.3 SUPPLY CHAIN ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 BUSINESS STRATEGY EXCELLENCE
4.6 CASE STUDIES
4.7 STRENGTH OF PRODUCT PORTFOLIO
4.8 TECHNOLOGICAL TRENDS
4.9 PRICING ANALYSIS
5 INDUSTRY INSIGHTS
6 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, REGULATIONS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 GROWING PREVALENCE OF CANCER, CHRONIC INFLAMMATION, AUTOIMMUNE DISEASE, LYME DISEASE, AND OTHER CHRONIC DEGENERATIVE DISEASES
7.1.2 INCREASING INVESTMENTS IN PHARMACEUTICAL R&D AND LIFE SCIENCES RESEARCH
7.1.3 AVAILABILITY OF VARIOUS EXOSOME ISOLATION AND PURIFICATION TECHNIQUES AND PROGRESSING THERAPEUTIC VALUE OF EXOSOME
7.2 RESTRAINTS
7.2.1 LACK OF GOLD STANDARD PROTOCOLS FOR THE DEVELOPMENT AND PRODUCTION OF EXOSOMES
7.2.2 THE SHORTAGE OF SKILLED PROFESSIONALS REQUIRED FOR THE ISOLATION OF EXOSOME
7.3 OPPORTUNITIES
7.3.1 RISING DEMAND FOR SPECIALIZED TESTING SERVICES AMONG END USERS.
7.3.2 INCREASING ADVANCEMENT IN EXOSOME TECHNOLOGY
7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
7.4 CHALLENGES
7.4.1 SIDE EFFECTS ASSOCIATED WITH EXOSOME RESEARCH PRODUCTS
7.4.2 LATE APPROVAL ASSOCIATED WITH PRODUCT LAUNCHES
8 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 CONSUMABLES
8.2.1 KITS AND REAGENTS
8.2.1.1 EXOSOME BIOMARKER KITS
8.2.1.2 EXOSOME ISOLATION KITS
8.2.1.3 EXOSOME PURIFICATION KITS
8.2.1.4 EXOSOME QUANTITATIVE KITS
8.2.1.5 EXOSOME DETECTION KITS
8.2.1.6 OTHERS
8.2.2 EXOSOME STANDARDS
8.2.3 EXOSOME ANTIBODIES
8.2.4 CELL LINES
8.2.5 IMMUNOPLATES
8.2.6 IMMUNOBEADS
8.2.7 BIOFLUIDS
8.2.8 OTHERS
8.3 INSTRUMENTS
8.3.1 BENCHTOP
8.3.2 STANDALONE
9 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION
9.1 OVERVIEW
9.2 CANCER
9.2.1 LUNG CANCER
9.2.2 BREAST CANCER
9.2.3 COLORECTAL CANCER
9.2.4 PROSTATE CANCER
9.2.5 OTHER CANCER
9.3 NON-CANCER
9.3.1 CARDIOVASCULAR DISEASE
9.3.2 NEURODEGENERATIVE DISEASE
9.3.3 INFECTIOUS DISEASE
9.3.4 OTHERS
10 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION
10.1 OVERVIEW
10.2 THERAPEUTICS
10.3 CONSUMABLES
10.4 INSTRUMENTS
10.5 DIAGNOSIS
10.6 CONSUMABLES
10.7 INSTRUMENTS
11 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER
11.1 OVERVIEW
11.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY
11.3 CONSUMABLES
11.4 INSTRUMENTS
11.5 RESEARCH CENTRES
11.6 CONSUMABLES
11.7 INSTRUMENTS
11.8 ACADEMIC INSTITUTES
11.9 CONSUMABLES
11.1 INSTRUMENTS
11.11 CLINICAL TESTING LABORATORY
11.12 CONSUMABLES
11.13 INSTRUMENTS
11.14 HOSPITALS
11.15 CONSUMABLES
11.16 INSTRUMENTS
11.17 OTHERS
12 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 THIRD PARTY DISTRIBUTORS
12.3 DIRECT SALES
12.4 ONLINE
13 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY REGION
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 THERMO FISHER SCIENTIFIC INC.
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 EXODX (ACQUIRED BY BIO-TECHNE)
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 MILTENYI BIOTEC
16.3.1 COMPANY SNAPSHOT
16.3.2 COMPANY SHARE ANALYSIS
16.3.3 PRODUCT PORTFOLIO
16.3.4 RECENT DEVELOPMENTS
16.4 LUMINEX CORPORATION
16.4.1 COMPANY SNAPSHOT
16.4.2 PRODUCT PORTFOLIO
16.4.3 RECENT DEVELOPMENT
16.5 HOLOGIC, INC.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 AETHLON MEDICAL, INC. (2022)
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 AGILENT TECHNOLOGIES, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENT
16.8 AMSBI0
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 AUDUBON BIOSCIENCE.
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 BECKMAN COULTER, INC
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENT
16.11 BIOVISION INC. (ACQUIRED BY ABCAM PLC)
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 COMPANY SHARE ANALYSIS
16.11.4 PRODUCT PORTFOLIO
16.11.5 RECENT DEVELOPMENT
16.12 CELL GUIDANCE SYSTEMS LLC
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 CREATIVE BIOARRAY
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 CUSABIO TECHNOLOGY LLC
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENTS
16.15 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENT
16.16 HBMLS (ACQUIRED BY LONZA)
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENT
16.17 HITACHI, LTD.
16.17.1 COMPANY SNAPSHOT
16.17.2 REVENUE ANALYSIS
16.17.3 PRODUCT PORTFOLIO
16.17.4 RECENT DEVELOPMENT
16.18 INOVIQ
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENT
16.19 JSR MICRO NV
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 MICROGENTAS
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENTS
16.21 NANOSOMIX
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 NEXOSOME-ONCOLOGY
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENTS
16.23 NORGEN BIOTEK CORP.
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENTS
16.24 NOVUS BIOLOGICALS
16.24.1 COMPANY SNAPSHOT
16.24.2 PRODUCT PORTFOLIO
16.24.3 RECENT DEVELOPMENT
16.25 PROTEOGENEX
16.25.1 COMPANY SNAPSHOT
16.25.2 PRODUCT PORTFOLIO
16.25.3 RECENT DEVELOPMENT
16.26 QIAGEN
16.26.1 COMPANY SNAPSHOT
16.26.2 REVENUE ANALYSIS
16.26.3 PRODUCT PORTFOLIO
16.26.4 RECENT DEVELOPMENT
16.27 ROOSTERBIO, INC.
16.27.1 COMPANY SNAPSHOT
16.27.2 PRODUCT PORTFOLIO
16.27.3 RECENT DEVELOPMENTS
16.28 SYSTEM BIOSCIENCES, LLC.
16.28.1 COMPANY SNAPSHOT
16.28.2 PRODUCT PORTFOLIO
16.28.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
表のリスト
TABLE 1 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, PRICING ANALYSIS
TABLE 2 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT , 2021-2030 (USD THOUSAND)
TABLE 3 NORTH AMERICA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 4 NORTH AMERICA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 5 NORTH AMERICA KITS AND REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 6 NORTH AMERICA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 7 NORTH AMERICA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 8 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 9 NORTH AMERICA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 10 NORTH AMERICA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 11 NORTH AMERICA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 12 NORTH AMERICA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 13 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 14 NORTH AMERICA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 15 NORTH AMERICA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 16 NORTH AMERICA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 17 NORTH AMERICA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 18 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 19 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 20 NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)
TABLE 21 NORTH AMERICA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 22 NORTH AMERICA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)
TABLE 23 NORTH AMERICA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 24 NORTH AMERICA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)
TABLE 25 NORTH AMERICA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 26 NORTH AMERICA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 27 NORTH AMERICA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 28 NORTH AMERICA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND)
TABLE 29 NORTH AMERICA OTHERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 30 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 31 NORTH AMERICA THIRD PARTY DISTRIBUTORS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 32 NORTH AMERICA DIRECT SALES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 33 NORTH AMERICA ONLINE IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 34 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)
TABLE 35 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)
TABLE 36 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 37 NORTH AMERICA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 38 NORTH AMERICA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 39 NORTH AMERICA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 40 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 41 NORTH AMERICA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 42 NORTH AMERICA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 43 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 44 NORTH AMERICA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 45 NORTH AMERICA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 46 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 47 NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 48 NORTH AMERICA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 49 NORTH AMERICA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 50 NORTH AMERICA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 51 NORTH AMERICA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 52 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 53 U.S. EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 54 U.S. CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 55 U.S. KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 56 U.S. INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 57 U.S. EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 58 U.S. CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 59 U.S. NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 60 U.S. EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 61 U.S. THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 62 U.S. DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 63 U.S. EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 64 U.S. PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 65 U.S. RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 66 U.S. ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 67 U.S. CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 68 U.S. HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 69 U.S. EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 70 CANADA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 71 CANADA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 72 CANADA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 73 CANADA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 74 CANADA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 75 CANADA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 76 CANADA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 77 CANADA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 78 CANADA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 79 CANADA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 80 CANADA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 81 CANADA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 82 CANADA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 83 CANADA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 84 CANADA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 85 CANADA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 86 CANADA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 87 MEXICO EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 88 MEXICO CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 89 MEXICO KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 90 MEXICO INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)
TABLE 91 MEXICO EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 92 MEXICO CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 93 MEXICO NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND)
TABLE 94 MEXICO EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 95 MEXICO THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 96 MEXICO DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 97 MEXICO EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 98 MEXICO PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 99 MEXICO RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 100 MEXICO ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 101 MEXICO CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 102 MEXICO HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 103 MEXICO EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
図表一覧
FIGURE 1 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: SEGMENTATION
FIGURE 11 THE INCREASE IN THE PREVALENCE OF CANCER AND OTHER AUTO-IMMUNE DISEASE IS EXPECTED TO DRIVE THE NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET GROWTH IN THE FORECAST PERIOD
FIGURE 12 THE CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET
FIGURE 14 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, 2022
FIGURE 15 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, 2023-2030 (USD THOUSAND)
FIGURE 16 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, 2022
FIGURE 19 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, 2023-2030 (USD THOUSAND)
FIGURE 20 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, CAGR (2023-2030)
FIGURE 21 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, LIFELINE CURVE
FIGURE 22 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, 2022
FIGURE 23 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND)
FIGURE 24 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, 2022
FIGURE 27 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, 2023-2030 (USD THOUSAND)
FIGURE 28 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND)
FIGURE 32 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: SNAPSHOT (2022)
FIGURE 35 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022)
FIGURE 36 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: PRODUCT (2023-2030)
FIGURE 39 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: COMPANY SHARE 2022 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
